Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Breast cancer in men.

Aman U Buzdar1

  • 1Department of Breast, University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.

Oncology (Williston Park, N.Y.)
|November 11, 2003
PubMed
Summary

Men with breast cancer typically present with a breast mass requiring tissue diagnosis. Treatment involves mastectomy for invasive cancer, with hormone-receptor status guiding adjuvant endocrine therapy, chemotherapy, or both.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular Characterization and Prospective Evaluation of Pathologic Response and Outcomes with Neoadjuvant Therapy in Metaplastic Triple-Negative Breast Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2022
Same author

Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action.

JCI insight·2020
Same author

Single-nucleotide polymorphism biomarkers of adjuvant anastrozole-induced estrogen suppression in early breast cancer.

Pharmacogenetics and genomics·2020
Same author

Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction Between SLC38A7 and ALPPL2.

Clinical pharmacology and therapeutics·2019
Same author

Disease-Free and Overall Survival Among Patients With Operable HER2-Positive Breast Cancer Treated With Sequential vs Concurrent Chemotherapy: The ACOSOG Z1041 (Alliance) Randomized Clinical Trial.

JAMA oncology·2018
Same author

A phase II study of tipifarnib and gemcitabine in metastatic breast cancer.

Investigational new drugs·2018

Area of Science:

  • Oncology
  • Endocrinology

Background:

  • Male breast cancer is rare, often presenting as a palpable breast mass.
  • Accurate diagnosis and staging are crucial for effective treatment planning.

Purpose of the Study:

  • To outline the diagnostic and therapeutic strategies for male breast cancer.
  • To emphasize the importance of hormone receptor status in treatment decisions.

Main Methods:

  • Review of clinical presentation and diagnostic workup for male breast cancer.
  • Discussion of surgical management, including mastectomy.
  • Analysis of adjuvant therapy options based on tumor characteristics.

Main Results:

  • Most male breast cancers are invasive and hormone-receptor positive.
  • Mastectomy is the standard local therapy for invasive disease.
  • Adjuvant therapy decisions are guided by risk stratification and receptor status.

Conclusions:

  • Early diagnosis and tissue confirmation are essential for men presenting with breast masses.
  • Treatment strategies, including adjuvant endocrine therapy and chemotherapy, should be tailored to hormone-receptor status and patient risk.
  • Endocrine therapy is a primary option for metastatic estrogen-receptor-positive disease.

Related Experiment Videos